Dr. David Sugarbaker,
Founder of the International Mesothelioma Program
Founded by David J. Sugarbaker, MD, the International Mesothelioma Program (IMP) encompasses both a clinical program and a research program. Our clinical focus is on developing treatment strategies that can significantly extend the life of our patients. Our research focus involves a collaboration of basic, translational, and clinical research scientists whose aim is to understand the causative factors in the development of the disease and to translate these findings into improved therapy.
Send Feedback to: 
